Pred Forte

/ AbbVie

1-2 drops into the conjunctival sac 2-4 times a day during the initial 24-48 hours. May increase the frequency if necessary.
See prescribing information for full details.

Steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea anterior segment of the globe.

Most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, in mycobacterial infection of the eye and fungal diseases of ocular structures. Known or suspected hypersensitivity to any of the ingredients or to other corticosteroids.

Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity, and fields of vision, and in posterior subcapsular cataract formation. Prolonged use may also suppress the host immune response and thus increase the hazard of secondary ocular infections. If infection is present, appropriate measures must be taken to counteract the organisms involved. Use of topical corticosteroids in the presence of thin corneal or scleral tissue may lead to perforation. If used for 10 days or longer, intraocular pressure should be routinely monitored. Use with caution in the presence of glaucoma. Renewal of the medicdbation order beyond 20 ml should be made only after examination of the patient with the aid of magnification. Fungal invasion should be suspected in any persistent corneal ulceration where a corticosteroid has been used or is in use. Pregnancy and lactation: Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Safety and effectiveness in pediatric patients have not been established. Not for injection into the eye.

Elevation of intraocular pressure with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing. Transient burning and stinging and other minor symptoms of ocular irritation, visual disturbance, allergic reactions.

Phenytoin, barbiturates, carbamazepine, aminoglutethimide, rifampicin. Thiazide and loop diuretics, cardiac glycosides, acetazolamide. Oral hypoglycemics, insulin, antihypertensives, anabolic steroids, ophthalmic idoxuridine. NSAIDs, aspirin, other salicylates, coumarin anticoagulants, vaccines, estrogens.